Patents by Inventor Steven Shaw

Steven Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240134038
    Abstract: This document describes techniques and systems for stationary object detection and classification based on low-level radar data. Raw electromagnetic signals reflected off stationary objects and received by a radar system may be preprocessed to produce low-level spectrum data in the form of range-Doppler maps that retain all or nearly all the data present in the raw electromagnetic signals. The preprocessing may also filter non-stationary range-Doppler bins. The remaining low-level spectrum data represents stationary objects present in a field-of-view (FOV) of the radar system. The low-level spectrum data representing stationary objects can be fed to an end-to-end deep convolutional detection and classification network that is trained to classify and provide object bounding boxes for the stationary objects. The outputted classifications and bounding boxes related to the stationary objects may be provided to other driving systems to improve their functionality resulting in a safer driving experience.
    Type: Application
    Filed: October 7, 2022
    Publication date: April 25, 2024
    Inventors: Shan Zhang, Kanishka Tyagi, Steven Shaw, Narbik Manukian
  • Patent number: 10928396
    Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIN1) isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+(e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: February 23, 2021
    Assignee: SARCOTEIN DIAGNOSTICS, LLC
    Inventors: Darryl Steven Shaw, Neil Gavin Shaw
  • Patent number: 10685170
    Abstract: In one embodiment, a content aggregation viewer may present a container layout to summarize a data item set to a user. The content aggregation viewer may determine a viewport dimension for a viewport of a user interface of a content aggregation application to present a data item set to a user. The content aggregation viewer may automatically arrange a container set summarizing the data item set in a container layout based on the viewport dimension. The content aggregation viewer may set a parallel container dimension of a data item container of the container set having a variable dimension size in a direction of the viewport dimension based on the viewport dimension. The content aggregation viewer may present the container set in the container layout to the user.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: June 16, 2020
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Jacek Ciereszko, Srinivas Patnaik, Steven Shaw, Hillary Mutisya
  • Patent number: 10436800
    Abstract: Provided are methods of determining if a subject has a cardiac disorder or is at risk for developing a cardiac disorder.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: October 8, 2019
    Assignee: SARCOTEIN DIAGNOSTICS, LLC
    Inventors: Darryl Steven Shaw, Neil Gavin Shaw
  • Patent number: 10321095
    Abstract: Pairing and configuring a computing device for use in a meeting space is provided. An appliance may communicate a broadcast to a computing device which announces the availability of a meeting space for a meeting. The computing device may establish a connection with the appliance. The computing device may then join the meeting in the meeting space.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: June 11, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Anton Krantz, William George Verthein, Srikanth Shoroff, Amey Parandekar, Mohammad N. Vakil, Steven Shaw, Nghiep Duong, Ankit Tandon
  • Publication number: 20180278890
    Abstract: Pairing and configuring a computing device for use in a meeting space is provided. An appliance may communicate a broadcast to a computing device which announces the availability of a meeting space for a meeting. The computing device may establish a connection with the appliance. The computing device may then join the meeting in the meeting space.
    Type: Application
    Filed: March 20, 2018
    Publication date: September 27, 2018
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Anton KRANTZ, William George VERTHEIN, Srikanth SHOROFF, Amey PARANDEKAR, Mohammad N. VAKIL, Steven SHAW, Nghiep DUONG, Ankit TANDON
  • Publication number: 20180172693
    Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIN1) isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+(e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.
    Type: Application
    Filed: November 30, 2017
    Publication date: June 21, 2018
    Applicant: Sarcotein Diagnostics, LLC
    Inventors: Darryl Steven Shaw, Neil Gavin Shaw
  • Publication number: 20180104288
    Abstract: The present invention relates to compositions and methods for treating cancer. More specifically, the present invention relates to compositions of engineered oncolytic viruses for administration to a subject with cancer that specifically lyse tumor cells and actively target tumor cells and cell debris to antigen presenting cells, in order to generate anti-tumor immunity.
    Type: Application
    Filed: April 7, 2016
    Publication date: April 19, 2018
    Inventors: Uri GALILI, Steven SHAW, Michael WESTBY
  • Patent number: 9942515
    Abstract: Pairing and configuring a computing device for use in a meeting space is provided. An appliance may communicate a broadcast to a computing device which announces the availability of a meeting space for a meeting. The computing device may establish a connection with the appliance. The computing device may then join the meeting in the meeting space.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: April 10, 2018
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Anton Krantz, William George Verthein, Srikanth Shoroff, Amey Parandekar, Mohammad N. Vakil, Steven Shaw, Nghiep Duong, Ankit Tandon
  • Patent number: 9891232
    Abstract: Provided are methods for determining skeletal muscle mass in subject. Also provided are methods for diagnosing a neurological condition or disease or a condition or disease associated with reduced skeletal muscle mass in a subject. Further provided are purified antibodies that bind specifically to a BIN1 polypeptide that is expressed specifically in skeletal muscle.
    Type: Grant
    Filed: November 7, 2011
    Date of Patent: February 13, 2018
    Assignee: Sarcotein Diagnostics, LLC
    Inventors: Darryl Steven Shaw, Neil Gavin Shaw
  • Publication number: 20180038874
    Abstract: Provided are methods of determining if a subject has a cardiac disorder or is at risk for developing a cardiac disorder.
    Type: Application
    Filed: March 2, 2016
    Publication date: February 8, 2018
    Applicant: Sarcotein Diagnostics, LLC
    Inventors: Darryl Steven SHAW, Neil Gavin SHAW
  • Patent number: 9846159
    Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIN1) isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+ (e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: December 19, 2017
    Assignee: Sarcotein Diagnostics, LLC
    Inventors: Darryl Steven Shaw, Neil Gavin Shaw
  • Patent number: 9716485
    Abstract: A frequency divider apparatus includes a micro-electro-mechanical system (“MEMS”) divider that is configured to be driven by an input signal. The MEMS divider includes a passive mechanical device that generates multiple output signals. Each of the output signals has a frequency less than a frequency of the input signal.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: July 25, 2017
    Assignees: Board of Trustees of Michigan State University, The Regents of the University of California
    Inventors: Steven Shaw, Brian S. Strachan, Kimberly L. Turner, Kamala Qalandar
  • Publication number: 20170177547
    Abstract: In one embodiment, a content aggregation viewer may present a container layout to summarize a data item set to a user. The content aggregation viewer may determine a viewport dimension for a viewport of a user interface of a content aggregation application to present a data item set to a user. The content aggregation viewer may automatically arrange a container set summarizing the data item set in a container layout based on the viewport dimension. The content aggregation viewer may set a parallel container dimension of a data item container of the container set having a variable dimension size in a direction of the viewport dimension based on the viewport dimension. The content aggregation viewer may present the container set in the container layout to the user.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 22, 2017
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Jacek Ciereszko, Srinivas Patnaik, Steven Shaw, Hillary Mutisya
  • Publication number: 20160125444
    Abstract: A computer-implemented system including a lead-engine server operatively coupled to an administrator computing system and a group of mobile devices. The lead-engine server may be configured to assign field user data among multiple campaign groups and define multiple, different campaigns for different groups of field users. The lead-engine server may also generate incentive programs and track the lead-generation input associated with the first field user. The lead-engine server may also be configured to generate a field-user specific website and communicate promotional information to potential leads that includes a link to the website.
    Type: Application
    Filed: October 27, 2015
    Publication date: May 5, 2016
    Inventors: Patrick Steven Shaw, Kurtis Wayne Frank, Charles Lynn Pate, JR.
  • Publication number: 20150357992
    Abstract: A frequency divider apparatus includes a micro-electro-mechanical system (“MEMS”) divider that is configured to be driven by an input signal. The MEMS divider includes a passive mechanical device that generates multiple output signals. Each of the output signals has a frequency less than a frequency of the input signal.
    Type: Application
    Filed: June 5, 2015
    Publication date: December 10, 2015
    Inventors: Steven SHAW, Brian S. STRACHAN, Kimberly L. Turner, Kamala Qalandar
  • Patent number: 9197049
    Abstract: The present disclosure is directed to a bracket and electrical assembly including such bracket for mounting or securing to a concrete masonry unit (CMU).
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: November 24, 2015
    Assignee: Cablofil, Inc.
    Inventors: Randy William Petak, Jeffrey Steven Shaw, Willie Franklin Fowler, Jr.
  • Patent number: 9094604
    Abstract: Imaging devices may include an array of image pixels arranged in rows and columns coupled to processing circuitry. The processing circuitry may include histogram generation circuitry and extremum pixel value identification circuitry. The histogram generation circuitry may include sub-histogram generation circuitry that generates pixel value sub-histograms each of which includes pixel values generated by pixels from respective subsets of the rows in the array. Histogram accumulation circuitry may combine the sub-histograms to generate an accumulated histogram. The extremum identification circuitry may process a set of pixel value patches. The identification circuitry may include a first stage of comparator circuitry for identifying an extremum value of each column in the set of patches, a second stage of comparator circuitry for identifying an extremum value of each patch in the set, and a third stage of comparator circuitry for identifying an extremum of the set of pixel value patches.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: July 28, 2015
    Assignee: Semiconductor Components Industries, LLC
    Inventor: Steven Shaw
  • Publication number: 20150096780
    Abstract: The present disclosure is directed to a bracket and electrical assembly including such bracket for mounting or securing to a concrete masonry unit (CMU).
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Randy William Petak, Jeffrey Steven Shaw, Willie Franklin Fowler, JR.
  • Publication number: 20150011594
    Abstract: Provided are methods for screening a subject for cancer. The methods involve obtaining a blood sample from the subject and determining a level of Bridging Integrator 1 (BIND isoforms comprising exon 12a in the sample. Optionally, the method involves determining a level of 12a+/13? BIN isoform (comprising exon 12a but lacking exon 13) in the sample. An elevated level of 12a+ (e.g., 12a+/13?) BIN1 isoforms in the blood sample indicates the subject has cancer. Also provided are methods for determining efficacy of a cancer therapy in a subject and methods of treating cancer. Isolated antibodies that selectively bind human 12a+ BIN1 are also provided as well as kits for determining 12a+/13? BIN1 isoforms.
    Type: Application
    Filed: September 28, 2012
    Publication date: January 8, 2015
    Inventors: Darryl Steven Shaw, Neil Gavin Shaw